902 related articles for article (PubMed ID: 25058336)
21. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
Chavdarova LI; Tzonevska AD; Piperkova EN
Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
[TBL] [Abstract][Full Text] [Related]
22. PET/MRI Evaluation of Gynecologic Malignancies and Prostate Cancer.
Bagade S; Fowler KJ; Schwarz JK; Grigsby PW; Dehdashti F
Semin Nucl Med; 2015 Jul; 45(4):293-303. PubMed ID: 26050657
[TBL] [Abstract][Full Text] [Related]
23. Hybrid Imaging in Oncology.
Fatima N; Zaman Mu; Gnanasegaran G; Zaman U; Shahid W; Zaman A; Tahseen R
Asian Pac J Cancer Prev; 2015; 16(14):5599-605. PubMed ID: 26320423
[TBL] [Abstract][Full Text] [Related]
24. Whole body simultaneous PET/MRI: one-stop-shop?
Maseeh-uz-Zaman ; Fatima N; Sajjad Z; Zaman U
J Pak Med Assoc; 2014 Feb; 64(2):201-4. PubMed ID: 24640813
[TBL] [Abstract][Full Text] [Related]
25. Variability of target and normal structure delineation using multimodality imaging for radiation therapy of pancreatic cancer.
Dalah E; Moraru I; Paulson E; Erickson B; Li XA
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):633-40. PubMed ID: 24755533
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
Beiderwellen KJ; Poeppel TD; Hartung-Knemeyer V; Buchbender C; Kuehl H; Bockisch A; Lauenstein TC
Invest Radiol; 2013 May; 48(5):273-9. PubMed ID: 23493121
[TBL] [Abstract][Full Text] [Related]
27. The added value of PET/Ce-CT/DW-MRI fusion in assessment of hepatic focal lesions: PET/Ce-CT/DW-MRI fusion in hepatic focal lesion.
Salem S; Houseni M; Zidan L; Kandil A
Nucl Med Biol; 2015 Jul; 42(7):637-42. PubMed ID: 25907467
[TBL] [Abstract][Full Text] [Related]
28. Clinical application of PET/MRI in oncology.
Sotoudeh H; Sharma A; Fowler KJ; McConathy J; Dehdashti F
J Magn Reson Imaging; 2016 Aug; 44(2):265-76. PubMed ID: 27007987
[TBL] [Abstract][Full Text] [Related]
29. [New trends and novel possibilities in the management of oncologic patients: clinical uses of PET/MRI].
Borbély K
Magy Onkol; 2015 Mar; 59(1):10-6. PubMed ID: 25763908
[TBL] [Abstract][Full Text] [Related]
30. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
[TBL] [Abstract][Full Text] [Related]
31. On the quantification accuracy, homogeneity, and stability of simultaneous positron emission tomography/magnetic resonance imaging systems.
Schmidt H; Schwenzer NF; Bezrukov I; Mantlik F; Kolb A; Kupferschläger J; Pichler BJ
Invest Radiol; 2014 Jun; 49(6):373-81. PubMed ID: 24368614
[TBL] [Abstract][Full Text] [Related]
32. Rationale for the combination of nuclear medicine with magnetic resonance for pre-clinical imaging.
Wagenaar DJ; Kapusta M; Li J; Patt BE
Technol Cancer Res Treat; 2006 Aug; 5(4):343-50. PubMed ID: 16866565
[TBL] [Abstract][Full Text] [Related]
33. PET-MRI: clinical application of the new hybrid technology.
Tudisca C; Nasoodi A; Fraioli F
Nucl Med Commun; 2015 Jul; 36(7):666-78. PubMed ID: 25830717
[TBL] [Abstract][Full Text] [Related]
34. PET/MRI: a new technology in the field of molecular imaging.
Afaq A; Syed R; Bomanji J
Br Med Bull; 2013; 108():159-71. PubMed ID: 24227824
[TBL] [Abstract][Full Text] [Related]
35. Innovations in Small-Animal PET/MR Imaging Instrumentation.
Tsoumpas C; Visvikis D; Loudos G
PET Clin; 2016 Apr; 11(2):105-18. PubMed ID: 26952725
[TBL] [Abstract][Full Text] [Related]
36. Contrast Media in PET/Computed Tomography Imaging.
Dhull VS; Rana N; Nazar AH
PET Clin; 2016 Jan; 11(1):85-94. PubMed ID: 26590446
[TBL] [Abstract][Full Text] [Related]
37. Positron emission tomography/MRI for cardiac diseases assessment.
Manabe O; Oyama-Manabe N; Tamaki N
Br J Radiol; 2020 Sep; 93(1113):20190836. PubMed ID: 32023123
[TBL] [Abstract][Full Text] [Related]
38. Application value of MRI combined with positron emission tomography (PET)/CT in diagnosis and preoperative staging of tongue squamous cell carcinoma.
Chen W; Zhang C; Zhang S; Liang L; Zhang B; Liu C; Zhang Z; Liang C
J Med Imaging Radiat Oncol; 2015 Apr; 59(2):170-8. PubMed ID: 25753588
[TBL] [Abstract][Full Text] [Related]
39. Hybrid imaging for pancreatic malignancy: clinical applications, merits, limitations, and pitfalls.
Jha P; Bijan B; Melendres G; Shelton DK
Clin Nucl Med; 2015 Mar; 40(3):206-13. PubMed ID: 25608151
[TBL] [Abstract][Full Text] [Related]
40. Hybrid PET/MR imaging: physics and technical considerations.
Shah SN; Huang SS
Abdom Imaging; 2015 Aug; 40(6):1358-65. PubMed ID: 25985965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
